Advertisement
News
Advertisement

Cephalon to Ask FDA for Additional Nuvigil Approval

Mon, 04/06/2009 - 5:08am
FRAZER, Pa. (AP) — Cephalon Inc. said Monday it hopes to ask the Food and Drug Administration to approve Nuvigil as a treatment for jet lag by the third quarter. The drug is already approved to treat several sleep disorders and is an updated version of Provigil, which also treats sleep disorders. Cephalon said Nuvigil met its goal in a late-stage study focusing on excessive sleepiness associated with jet lag. The company is also studying Nuvigil as a potential treatment for bipolar disorder.
Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading